Drugs / KHK2898
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01516645 | Jan 2012 → May 2015 | cancer | Kyowa Kirin, Inc. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KHK2898 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01516645 ↗ |
| Modality | Monoclonal antibody | “Anti-CD98 Monoclonal Antibody KHK2898” NCT01516645 ↗ |
| Route | Other | “injection” NCT01516645 ↗ |